Intravenous and Oral Pharmacokinetic Evaluation of a 2-Hydroxypropyl-β-cyclodextrin-Based Formulation of Carbamazepine in the Dog: Comparison with Commercially Available Tablets and Suspensions
- 1 March 1997
- journal article
- research article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (3), 335-339
- https://doi.org/10.1021/js9602913
Abstract
Complexation of carbamazepine with 2-hydroxypropyl-beta-cyclodextrin was performed to provide improved formulations of this widely used antiepileptic drug. Based on this approach, liquid dosage forms were configured for both parenteral and oral use. Intravenous administration of an aqueous carbamazepine x 2-hydroxypropyl-beta-cyclodextrin (CBZ x HPbetaCD) complex at a CBZ dose of 20 mg/kg was well tolerated and generated high initial drug levels that fell monoexponentially as a function of time, yielding a plasma elimination half-life of 38 min. Oral studies were completed with three preparations: a commercially available tablet and suspension, as well as a CBZ x HPbetaCD oral solution. Oral administration of tablets gave erratic and slow absorption, leading to maximum CBZ concentrations (C(max)) of <2 microg/mL, which were manifested only at 2.5 h after drug dosing. The absolute bioavailability of CBZ from the tablets was approximately 25%. Both the suspension and CBZ x HPbetaCD solution gave a significantly improved profile. Thus, the liquid oral dosage forms approximately doubled the oral bioavailability of CBZ compared with the tablets.Keywords
This publication has 12 references indexed in Scilit:
- Preparation, Characterization, and Anesthetic Properties of 2-Hydroxypropyl-β-cyclodextrin Complexes of Pregnanolone and Pregnenolone in Rat and MouseJournal of Pharmaceutical Sciences, 1995
- A Pharmacodynamic Approach to the Estimate of Carbamazepine AutoinductionJournal of Pharmaceutical Sciences, 1994
- Improvement of oral bioavailability of carbamazepine by inclusion in 2-hydroxypropyl-β-cyclodextrinInternational Journal of Pharmaceutics, 1992
- The Bioinequivalence of Carbamazepine Tablets with a History of Clinical FailuresPharmaceutical Research, 1992
- Development of Aqueous Parenteral Formulations for Carbamazepine through the Use of Modified CyclodextrinsJournal of Pharmaceutical Sciences, 1991
- An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys☆International Journal of Pharmaceutics, 1990
- The use of 2-hydroxypropyl-β-cyclodextrin as a vehicle for intravenous administration of dexamethasone in dogsInternational Journal of Pharmaceutics, 1990
- The metabolism of carbamazepine in humans: steric course of the enzymic hydrolysis of the 10,11-epoxideJournal of Medicinal Chemistry, 1987
- A Comparative Bioavailability Study of Carbamazepine Tablets and a Chewable Tablet FormulationTherapeutic Drug Monitoring, 1987
- Simultaneous First- and Zero-Order Absorption of Carbamazepine Tablets in HumansJournal of Pharmaceutical Sciences, 1986